導師資訊

Macau University of Science and Technology

MUST-SKL of Quality Research in Chinese Medicine

https://www.must.edu.mo/images/SKL/files/BaiLiPing_TC.pdf

新型S1P1調節劑治療特發性肺纖維化的創新藥物研究

Innovative drug research of novel S1P1 modulator for the treatment of idiopathic pulmonary fibrosis

1007 药学

0202 应用经济学,0702 物理学,0703 化学,0704 天文学,0705 地理学,0707 海洋科学,0708 地球物理学,0709 地质学,0710 生物学,0713 生态学,0802 机械工程,0803 光学工程,0805 材料科学与工程,0807 动力工程及工程热物理,0808 电气工程,0809 电子科学与技术,0810 信息与通信工程,0811 控制科学与工程,0814 土木工程,0827 核科学与技术,0831 生物医学工程,1001 基础医学,1004 公共卫生与预防医学,1007 药学,1008 中药学

The candidates should have experiences in either Medicinal chemistry or Pharmacological evaluation (being familiar with animal models in pulmonary fibrosis is preferable).

主要從事中藥中生物活性成分研究；活性有机小分子的結構修飾及其藥效研究 (FDCT 0074/2019/AMJ, FDCT project, MOP 2,101,000.00)；新型鞘脂的設計合成及其在藥物製劑領域中的應用研究；中藥質量標準研究(FDCT 0043/2020/AGJ, FDCT project, MOP1,048,000.00)。 bioactive ingredients in traditional Chinese medicines (TCM), structural modification of bioactive small molecules, and pharmacodynamic evaluations, design and synthesis of novel sphingolipids, and their application in the field of pharmaceutical preparations, and quality standards of TCM.

6

4

4

Project titles: 新型S1P1調節劑治療特發性肺纖維化的創新藥物研究, Funding sources: 澳門科學技術發展基金與國家科技部聯合科研資助項目, Reference number: 0074/2019/AMJ, Funding amounts: 210.1万澳门币, Duration: from 21th September 2020 to 21th September 2023.